Treatment patterns of oral corticosteroid and nonsteroidal immunosuppressant therapy and clinical outcomes in US patients receiving ravulizumab or eculizumab for generalized myasthenia gravis

Svetlana Faktorovich, Marcus Neuroscience Institute

Abstract